Average Co-Inventor Count = 10.06
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (21 from 2,405 patents)
2. Merck + Co., Inc. (1 from 4,770 patents)
3. Mochida Paraceuticals Co., Ltd. (1 from 1 patent)
4. Merck Shapr & Dohme Corp. (1 from 1 patent)
5. Mochida Pharmaceutical Co., Ltd. (227 patents)
23 patents:
1. 11530250 - Tyrosine-specific functionalized insulin and insulin analogs
2. 10399972 - Tricyclic compounds as inhibitors of mutant IDH enzymes
3. 10189819 - Factor IXa inhibitors
4. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
5. 9834563 - Antidiabetic substituted heteroaryl compounds
6. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
7. 9540364 - Benzimidazole tetrahydrofuran derivatives
8. 9527875 - Antidiabetic tricyclic compounds
9. 9527839 - Benzimidazole tetrahydropyran derivatives
10. 9382243 - Azabenzimidazole tetrahydropyran derivatives
11. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
12. 9029377 - Platelet-activating factor receptor antagonists
13. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
14. 8729104 - Diphenyl substituted alkanes as flap inhibitors
15. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists